MWNA
NEUE

Marshall Wace North America’s NeueHealth NEUE Stock Holding History

Marshall Wace North America’s Portfolio NEUE Stock Details NEUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$297K Sell
456
-10,047
-96% -$8.84M ﹤0.01% 1244
2021
Q2 		$14.4M Buy
+10,503
New +$14.4M 0.06% 310

Other funds holding NEUE

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
DIC
Deer IX & Co Larchmont, New York $971M AUM 24.77% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $24B AUM 39.59% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
PGH
Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Marshall Wace North America's NEUE Position: Q3 2021 in Review

Marshall Wace North America reduced its NeueHealth (NEUE) stake by 96% in Q3 2021, selling an estimated $8.84M and leaving 456 shares worth $297K. The position accounts for ﹤0.01% of the portfolio, ranked #1244.

Marshall Wace North America first reported a position in NEUE in Q2 2021 and has held it in 2 quarters since. The position peaked at $14.4M in Q2 2021. 102 funds tracked by Wall St. Rank hold NEUE as of Q3 2021.

  • Marshall Wace North America held 456 shares of NeueHealth worth $297K as of Q3 2021.
  • Marshall Wace North America sold 10,047 NeueHealth shares in Q3 2021, an estimated $8.84M.
  • NeueHealth made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1244 holding.
  • Marshall Wace North America first reported a position in NeueHealth in Q2 2021 and has held it in 2 quarters since.
  • Marshall Wace North America's NeueHealth position peaked at $14.4M in Q2 2021.
  • 102 funds tracked by Wall St. Rank held NeueHealth as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.